Authors

• Josefin Eklöf (ORCID: https://orcid.org/0000-0003-3739-7526)
• Valdemar Rømer (ORCID: https://orcid.org/0000-0002-1814-7639)
• Tobias Wirenfeldt Klausen (ORCID: https://orcid.org/0000-0002-1339-3275)
• John Robert Hurst (ORCID: https://orcid.org/0000-0002-7246-6040)
• Manan Pareek (ORCID: https://orcid.org/0000-0002-0867-5825)
• Jens‐Ulrik Stæhr Jensen (ORCID: https://orcid.org/0000-0003-4036-0521)
• Alexander G. Mathioudakis (ORCID: https://orcid.org/0000-0002-4675-9616)
• Daniel Modin (ORCID: https://orcid.org/0000-0002-7566-0519)
• Niklas Dyrby Johansen (ORCID: https://orcid.org/0000-0001-6959-3236)
• Tor Biering‐Sørensen (ORCID: https://orcid.org/0000-0003-4209-2778)
• Jørgen Vestbo (ORCID: https://orcid.org/0000-0001-6355-6362)
• Pradeesh Sivapalan (ORCID: https://orcid.org/0000-0002-8620-3655)
• Alexander Jordan
• Anna Kubel Vognsen

Institutions

• University of Copenhagen (DK)
• Steno Diabetes Centers (DK)
• Manchester Academic Health Science Centre (GB)
• Copenhagen University Hospital (DK)
• Gentofte Hospital (DK)
• Rigshospitalet (DK)
• Manchester University NHS Foundation Trust (GB)
• Wythenshawe Hospital (GB)
• University College London (GB)

Publication Details

Journal

BMC Pulmonary Medicine

Published

2025-12-03

DOI

https://doi.org/10.1186/s12890-025-03952-y

Primary Topic

Chronic Obstructive Pulmonary Disease (COPD) Research

Type

article

Field-Weighted Citation Impact

0.00

Funders

• Amgen
• AstraZeneca
• Sanofi
• Hjerteforeningen
• Boston Scientific Corporation
• Novo Nordisk
• Seqirus
• Sanofi Pasteur
• Cilag